Komorbiditesi olan hastalarda transüretral prostat rezeksiyonunun postoperatif sonuçları
Küçük Resim Yok
Tarih
2013
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Maltepe Üniversitesi
Erişim Hakkı
Attribution-NonCommercial-NoDerivs 3.0 United States
info:eu-repo/semantics/openAccess
info:eu-repo/semantics/openAccess
Özet
Amaç: Çalışmanın amacı, BPH nedeniyle transüretral prostat rezeksiyonu yapılmış hipertansiyon (HT), koroner arter hastalığı (KAH), diabetes mellitusu (DM) ve kronik obstrüktif akciğer hastalığı (KOAH) gibi komorbiditeleri olan hastalarda, postoperatif 12. ayda IPSS, Qmax, erektil durum ve üretra darlığı gibi klinik verileri değerlendirmektir. Gereç ve yöntem: Eylül 2009'dan Aralık 2011'e kadar TURP yapılan 85 hasta değerlendirildi. Preoperatif parametrelere yaş, Uluslararası Prostat Semptom Skoru (IPSS), Uluslararası Erektil Fonksiyon Indeksi (IIEF), prostat hacmi, postvoiding rezidü, maksimum akım(Qmax) dahildi. Ameliyat sırasındaki veriler ve postop 12. Aydaki IPSS, IIEF, Qmax, üretra darlığı oranları değerlendirildi. Bulgular: Seksen beş hastaya TURP yapıldı. Hastaların hepsinde bir veya daha fazla komorbidite vardı. Ortalama operasyon süresi 59.8±17.8 dakikaydı. Preoperatif /postoperatif 12. Ayda IIEF ve IPSS skorları sırasıyla; 18.6±7.8/15.0 ± 6.5 (p<0.05) ve, 18.6±7.8/10.0 ±7.3 (p<0.05) idi. Qmax:8.5±2.7 /20.0 ±4.9 (p<0.05) olarak bulundu. Üretra darlığı oranları 3/85 (% 3) olarak bulundu. Sonuçlar: BPH lı hastada TURP, IPSS, Qmax ve erektil fonksiyon da anlamlı oranda iyileşme sağlamaktadır. Üretra darlığı oranları kabul edilebilir düzeydedir
Aim: The aim of this study is to evaluate the pre/perioperative data and 12 month postoperative clinical data including IPSS, Qmax, erectile function status and urethral stricture rate in patients with comorbidities such as hypertension (HT), coronary artery disease (CAD), diabetes mellitus (DM) and chronic obstructive pulmonary disease (COPD) undergoing transurethral resection of the prostate (TURP) for symptomatic benign prostatic hyperplasia (BPH). Materials and methods: The data of 85 patients undergoing TURP from September 2009 to December 2011 were retrospectively evaluated. The preoperative parameters included age, prostate volume, International Prostate Symptom Score (IPSS), International Index of Erectile Function (IIEF) questionnaire, prostate volume, postvoiding residue, maximum flow (Qmax) and comorbidities. Perioperative data and 12 month postoperative IPSS, Qmax, urethral stricture incidence were evaluated and mean potency status of patients were evaluated with postoperative IIEF scores. Results: Eighty-five patients underwent TURP. All patients had one or more comorbidities. The mean operative time was 59.8±17.8. The preoperative/ postoperative 12 month IIEF score and IPSS were 18.6±7.8/15.0 ± 6.5 (p<0.05) and 18.6±7.8/10.0 ±7.3(p<0.05). Qmax were 8.5±2.7/20.0 ±4.9 (p<0.05). Urethral stricture rate was 3/85 (3%) at postoperative 12 month after TURP Conclusion: TURP provided significant improvement in IPSS and Qmax and erectile function. The urethral stricture rates are acceptable.
Aim: The aim of this study is to evaluate the pre/perioperative data and 12 month postoperative clinical data including IPSS, Qmax, erectile function status and urethral stricture rate in patients with comorbidities such as hypertension (HT), coronary artery disease (CAD), diabetes mellitus (DM) and chronic obstructive pulmonary disease (COPD) undergoing transurethral resection of the prostate (TURP) for symptomatic benign prostatic hyperplasia (BPH). Materials and methods: The data of 85 patients undergoing TURP from September 2009 to December 2011 were retrospectively evaluated. The preoperative parameters included age, prostate volume, International Prostate Symptom Score (IPSS), International Index of Erectile Function (IIEF) questionnaire, prostate volume, postvoiding residue, maximum flow (Qmax) and comorbidities. Perioperative data and 12 month postoperative IPSS, Qmax, urethral stricture incidence were evaluated and mean potency status of patients were evaluated with postoperative IIEF scores. Results: Eighty-five patients underwent TURP. All patients had one or more comorbidities. The mean operative time was 59.8±17.8. The preoperative/ postoperative 12 month IIEF score and IPSS were 18.6±7.8/15.0 ± 6.5 (p<0.05) and 18.6±7.8/10.0 ±7.3(p<0.05). Qmax were 8.5±2.7/20.0 ±4.9 (p<0.05). Urethral stricture rate was 3/85 (3%) at postoperative 12 month after TURP Conclusion: TURP provided significant improvement in IPSS and Qmax and erectile function. The urethral stricture rates are acceptable.
Açıklama
Anahtar Kelimeler
benin prostat hiperplazisi, transüretral prostat rezeksiyonu, erektil fonksiyon, üretra darlığı, benign prostatic hyperplasia, transurethral resection of the prostate (TURP), erectile function, urethral stricture
Kaynak
Maltepe Tıp Dergisi
WoS Q Değeri
Scopus Q Değeri
Cilt
5
Sayı
1
Künye
Sinanoğlu, O. ve Ekici, S. (2013). Komorbiditesi olan hastalarda transüretral prostat rezeksiyonunun postoperatif sonuçları / Postoperative outcomes of transurethral resection of the prostate in patients with comorbidities. Maltepe Tıp Dergisi. 5(1), s. 9-12.
